Article info

Download PDFPDF

Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study

Authors

  1. Correspondence to Professor Holger Reinecke; holger.reinecke{at}ukmuenster.de
View Full Text

Citation

Reinecke H, Jürgensmeyer S, Engelbertz C, et al
Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study

Publication history

  • Received March 6, 2018
  • Revised May 30, 2018
  • Accepted July 25, 2018
  • First published September 10, 2018.
Online issue publication 
September 10, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.